180 likes | 190 Views
TB Eradication Expenditure . Angela Robinson Assistant Principal Officer ERAD Division TB Conference Carlton Hotel 9 –10 October 2007. TB Programme – Expenditure. Overview How much does the TB Eradication Programme cost? How is the TB programme financed?
E N D
TB Eradication Expenditure Angela Robinson Assistant Principal Officer ERAD Division TB Conference Carlton Hotel 9 –10 October 2007
TB Programme – Expenditure Overview • How much does the TB Eradication Programme cost? • How is the TB programme financed? • Main expenditure items, including compensation
TB Programme - Grossexpenditure (not incl. admin costs) €m 1999 49.5 2000 45.5 2001 34.7 2002 40.7 2003 40.1 2004 36.3 2005 39.6 2006 38.3
TB Programme – Gross Expenditure Millions
TB Programme expenditure – sources of funding • National Exchequer • Farmer levies • Estimated €13.9m in 1996 • Estimated €10.4m in 2006 • Further reduction in 2007 • EU contribution
TB Programme – main expenditure items • Vet fees for herd testing • Reactor collection service • Supplies – purchase of tuberculin, kits • Wildlife programme • Research • Compensation • DAFF administrative costs
Main expend items - Vet fees – herd testing • Pre 1996 all testing was paid by DAF • Post 1996 to date farmer pays for one test per year except where reactors are disclosed • Total spend on vet fees in 2006 was €8.59m
Main expend itemsReactor collection service • Reactor collection from farm direct to slaughter plant • Objective: rapid removal minimises risk of spread of disease • Hauliers engaged following tender invitation • Cost of RCS in 2006 was €0.8m
Main expend items -Supplies • Supplies including tuberculin (€4m), supply of kits, lab equipment supplies • Total spend on supplies in 2006 was €5m
Main expend items –Wildlife programme • 2000 Partnership Agreement • Committed to enhancing wildlife strategy • Funding increased from €1m in 2000 to €2.6m in 2006
Main expend items –Research • Funding provided for: • Centre for Veterinary Epidemiology and Risk Analysis (CVERA) • The TB Diagnostics and Immunology Research Centre • The Badger Vaccine project • Various post-graduate studies • Policy advice and epid. and scientific research • Total spend on research 2000 was €1.1m and in 2006 was €2m
Main expend items - Compensation Schemes • On Farm Market Valuation Payment • Income Supplement • Depopulation Grant • Hardship Grant • Penalties up to 100% where there are breaches of terms and conditions, legislation and/or disease control requirements
On Farm Market Valuation - main terms • Replaced reactor grant (flat rate) • Fully rolled out in 2002 • Market value – in line with EU Task Force recommendation - subject to ceilings • €2,800 (inclusive of factory salvage price) per individual animal • €3,500 for one pedigree stock bull per breakdown episode
On-Farm Market Valuation - main terms contd. • Independent valuation • Guideline market prices compiled weekly from selected marts issued to valuers • Salvage value paid by factory to farmer • DAFF pays difference between salvage value and market value • DAFF pays full costs of 1st valuation • Appeal and arbitration mechanisms
Depopulation – main terms • Objective: to compensate farmers for loss of income arising from depopulation • Herdowner must agree to depopulation at the time specified by the Department • Payable for animals removed where full or partial depopulation is considered appropriate
Income Supplement – main terms • Objective: to compensate farmers for loss of income arising from removal of animals • Payable where removal is > than 10% of animals • Depopulation not considered appropriate • Maximum: first 100 animals only
Hardship Grant – main terms • Assists farmers with additional feed costs where animals are retained/fed during periods of restriction • Eligibility period between 1 November and 30 April • Following reactor re-test • No off-farm income • No income from milk sales • Maximum €250.00 per month for a period not exceeding 4 months during eligibility period
Conclusion - Objective of DAFF financial intervention • Compensation • removal of privately owned assets • loss of income arising from restriction of movements • Minimises risk of failure to disclose disease • Payment for herd testing supports regulatory framework of the testing regime to progress eradication • Rapid removal of reactors minimises risk of further spread of disease • Research to underpin eradication/wildlife policy, including in particular, the development of vaccine